As of 2026-01-25, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 705.26 USD. This relative valuation is based on P/E multiples. With the latest stock price at 753.55 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is -6.4%.
The range of the Relative Valuation is 659.34 - 964.52 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 16.5x | 16.2x |
| Forward P/E multiples | 15.3x - 22.4x | 16.4x |
| Fair Price | 659.34 - 964.52 | 705.26 |
| Upside | -12.5% - 28.0% | -6.4% |
| Date | P/E |
| 2026-01-23 | 17.30 |
| 2026-01-22 | 17.34 |
| 2026-01-21 | 17.20 |
| 2026-01-20 | 16.85 |
| 2026-01-16 | 16.83 |
| 2026-01-15 | 17.03 |
| 2026-01-14 | 17.31 |
| 2026-01-13 | 17.42 |
| 2026-01-12 | 17.63 |
| 2026-01-09 | 18.29 |
| 2026-01-08 | 18.39 |
| 2026-01-07 | 18.65 |
| 2026-01-06 | 17.83 |
| 2026-01-05 | 17.52 |
| 2026-01-02 | 17.82 |
| 2025-12-31 | 17.72 |
| 2025-12-30 | 17.77 |
| 2025-12-29 | 17.92 |
| 2025-12-26 | 18.02 |
| 2025-12-24 | 17.99 |
| 2025-12-23 | 18.03 |
| 2025-12-22 | 17.89 |
| 2025-12-19 | 17.63 |
| 2025-12-18 | 17.19 |
| 2025-12-17 | 17.21 |
| 2025-12-16 | 17.13 |
| 2025-12-15 | 17.28 |
| 2025-12-12 | 17.02 |
| 2025-12-11 | 17.14 |
| 2025-12-10 | 16.67 |
| 2025-12-09 | 15.90 |
| 2025-12-08 | 16.15 |
| 2025-12-05 | 16.49 |
| 2025-12-04 | 16.59 |
| 2025-12-03 | 16.61 |
| 2025-12-02 | 17.03 |
| 2025-12-01 | 17.22 |
| 2025-11-28 | 17.91 |
| 2025-11-26 | 18.01 |
| 2025-11-25 | 18.07 |
| 2025-11-24 | 17.48 |
| 2025-11-21 | 17.35 |
| 2025-11-20 | 16.92 |
| 2025-11-19 | 16.13 |
| 2025-11-18 | 16.65 |
| 2025-11-17 | 16.17 |
| 2025-11-14 | 15.92 |
| 2025-11-13 | 15.96 |
| 2025-11-12 | 15.65 |
| 2025-11-11 | 15.49 |